Israel Englander Aslan Pharmaceuticals LTD Transaction History

Millennium Management LLC

$199 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$0.36 - $24.24 $23,322 - $1.57 Million	64,784 Added 4.08%	1,654,153 $595,000
Q3 2022 Nov 14, 2022	SELL	$0.42 - $24.68 $9,972 - $586,001	-23,744 Reduced 1.47%	1,589,369 $953,000
Q2 2022 Aug 15, 2022	BUY	$0.36 - $0.9 $15,821 - $39,554	43,949 Added 2.8%	1,613,113 $804,000
Q1 2022 May 16, 2022	SELL	$0.74 - $1.22 $36,971 - $60,952	-49,961 Reduced 3.09%	1,569,164 $1.39 Million
Q4 2021 Feb 14, 2022	BUY	$1.11 - $1.86 $167,518 - $280,707	150,918 Added 10.28%	1,619,125 $1.81 Million
Q3 2021 Nov 15, 2021	BUY	$1.78 - $3.41 $211,675 - $405,513	118,919 Added 8.81%	1,468,207 $2.61 Million
Q2 2021 Aug 16, 2021	BUY	$2.5 - $3.72 $257,532 - $383,208	103,013 Added 8.27%	1,349,288 $4.45 Million
Q1 2021 May 17, 2021	BUY	$1.86 - $5.25 $2.32 Million - $6.54 Million	1,246,275 New	1,246,275 $4.18 Million
Q3 2020 Nov 16, 2020	SELL	$1.41 - $2.04 $26,925 - $38,955	-19,096 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$0.96 - $2.19 $18,332 - $41,820	19,096 New	19,096 $37,000
Q3 2019 Nov 14, 2019	SELL	$1.51 - $3.85 $17,369 - $44,286	-11,503 Closed	0 $0
Q2 2019 Aug 15, 2019	SELL	$2.91 - $4.5 $354,155 - $547,663	-121,703 Reduced 91.36%	11,503 $35,000
Q2 2019 Aug 14, 2019	BUY	$2.91 - $4.5 $343,944 - $531,873	118,194 Added 787.33%	133,206 $24.6 Million
Q1 2019 May 14, 2019	SELL	$3.1 - $4.8 $9,724 - $15,057	-3,137 Reduced 17.28%	15,012 $62,000
Q4 2018 Feb 14, 2019	SELL	$2.86 - $8.0 $44,138 - $123,464	-15,433 Reduced 45.96%	18,149 $72,000
Q3 2018 Nov 14, 2018	SELL	$7.3 - $8.5 $51,508 - $59,976	-7,056 Reduced 17.36%	33,582 $258,000
Q2 2018 Aug 14, 2018	BUY	$5.48 - $10.24 $222,696 - $416,133	40,638 New	40,638 $358,000

Others Institutions Holding ASLN

# of Institutions

Shares Held

Call Options Held

Put Options Held

Concourse Financial Group Securities, Inc. Birmingham, AL

0
Shares

$0
0.0% of portfolio

View Full List

About ASLAN Pharmaceuticals Ltd

Ticker ASLN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,744,704
Market Cap $41.8M
Description
ASLAN Pharmaceuticals Limited, a clinical-stage immunology focused biopharmaceutical company, engages in developing various treatments to transform the lives of patients. The company's clinical portfolio comprises ASLAN004, a monoclonal therapy that is being developed in atopic dermatitis and other immunology indications; and ASLAN003, a small-m...

More about ASLN

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account